| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11899-018-0442-1 |
| P698 | PubMed publication ID | 29442287 |
| P2093 | author name string | Michael G Douvas | |
| Victor M Orellana-Noia | |||
| P2860 | cites work | Chimeric antigen receptor T cells for sustained remissions in leukemia | Q29617588 |
| Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434 | Q30300395 | ||
| A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias | Q33411250 | ||
| The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer | Q33993529 | ||
| Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study | Q34278437 | ||
| Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia | Q34314927 | ||
| Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update | Q34743455 | ||
| Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids | Q35065477 | ||
| Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. | Q35976588 | ||
| Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial. | Q36297416 | ||
| Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission | Q36609579 | ||
| What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies | Q36843677 | ||
| Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncolog | Q36914391 | ||
| High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia | Q37163738 | ||
| Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232 | Q37169331 | ||
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia | Q37624584 | ||
| Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults | Q37695157 | ||
| High-throughput sequencing for noninvasive disease detection in hematologic malignancies. | Q38672646 | ||
| Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study | Q39396416 | ||
| T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial | Q40186710 | ||
| Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia | Q40312849 | ||
| Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia | Q40705613 | ||
| Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen | Q40754724 | ||
| Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia | Q43457128 | ||
| The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. | Q45062542 | ||
| Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia | Q45350220 | ||
| Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. | Q46021126 | ||
| Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis | Q46196747 | ||
| ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study. | Q46441613 | ||
| Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group | Q47330036 | ||
| Use of a Fitness Tracker to Promote Physical Activity in Children With Acute Lymphoblastic Leukemia. | Q53216046 | ||
| Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003. | Q53239133 | ||
| Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter S | Q56959848 | ||
| Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the P | Q62607764 | ||
| P921 | main subject | teenager | Q1492760 |
| P577 | publication date | 2018-02-14 | |
| P1433 | published in | Current hematologic malignancy reports | Q26842233 |
| P1476 | title | Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia |
| Q91646509 | Emerging Cancer Survival Trends, Disparities, and Priorities in Adolescents and Young Adults: A California Cancer Registry-Based Study | cites work | P2860 |
Search more.